|
Statistics and Research Methods
Citations 331-340 of 1015 total displayed.
|
Past content
(since Jan 1998):
|
- Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
- Serban-Dan Costa
JAMA 2008; 300: 902-a-903-a.
[Extract]
[Full text]
[PDF]
- Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
- Richard Balon
JAMA 2008; 300: 902.
[Extract]
[Full text]
[PDF]
- Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
- Hean T. Ong; Jin S. Cheah
JAMA 2008; 300: 903-a-904-a.
[Extract]
[Full text]
[PDF]
- Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
- Hervé Maisonneuve
JAMA 2008; 300: 903.
[Extract]
[Full text]
[PDF]
- Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies—Reply
- Joseph S. Ross; David S. Egilman; Harlan M. Krumholz
JAMA 2008; 300: 904-b-905-b.
[Extract]
[Full text]
[PDF]
- Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies—Reply
- Bruce M. Psaty; Richard A. Kronmal
JAMA 2008; 300: 904-a.
[Extract]
[Full text]
[PDF]
- Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
- Peter A. Lachenbruch; Ronald Wasserstein
JAMA 2008; 300: 904.
[Extract]
[Full text]
[PDF]
- Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies—Reply
- Catherine D. DeAngelis; Phil B. Fontanarosa
JAMA 2008; 300: 905-906.
[Extract]
[Full text]
[PDF]
- Commentaries
Opportunities for Enhancing the FDA Guidance on Pharmacovigilance
- Bruce M. Psaty; Jan P. Vandenbroucke
JAMA 2008; 300: 952-954.
[Extract]
[Full text]
[PDF]
- Editorials
Tight Glycemic Control in Critically Ill Adults
- Simon Finfer; Anthony Delaney
JAMA 2008; 300: 963-965.
[Extract]
[Full text]
[PDF]
|
|
